©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 106910
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.106910
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.106910
Table 3 Comparison of serum tumor markers (carbohydrate antigen 19-9, carcinoembryonic antigen), serum soluble intercellular adhesion molecule-1, and chitinase-3-like protein 1 Levels in patients with pancreatic cancer at different tumor-node-metastasis stages, mean ± SD
| Group | n | CA-19-9 (U/mL) | CEA (U/mL) | sICAM-1 (μg/L) | CHI3 L1 (ng/mL) |
| Stage I pancreatic cancer | 24 | 98.43 ± 6.21 | 8.62 ± 1.12 | 213.51 ± 26.31 | 167.92 ± 5.47 |
| Stage II pancreatic cancer | 27 | 131.37 ± 22.58 | 12.39 ± 2.22 | 254.82 ± 25.79 | 192.46 ± 11.39 |
| t | - | 10.045 | 10.828 | 8.007 | 13.870 |
| P value | - | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
- Citation: Deng QX, Tang XL, Yuan GJ, Jian Q, Chen XH, Wu LJ. Study of serum tumor markers in the early diagnosis of pancreatic cancer. World J Gastrointest Oncol 2025; 17(9): 106910
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/106910.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.106910